Zhejiang Jolly Pharmaceutical Co.,LTD

SZSE:300181 Stock Report

Market Cap: CN¥8.2b

Zhejiang Jolly PharmaceuticalLTD Balance Sheet Health

Financial Health criteria checks 6/6

Zhejiang Jolly PharmaceuticalLTD has a total shareholder equity of CN¥2.7B and total debt of CN¥240.7M, which brings its debt-to-equity ratio to 8.9%. Its total assets and total liabilities are CN¥3.9B and CN¥1.2B respectively. Zhejiang Jolly PharmaceuticalLTD's EBIT is CN¥534.9M making its interest coverage ratio -42.3. It has cash and short-term investments of CN¥925.9M.

Key information

8.9%

Debt to equity ratio

CN¥240.71m

Debt

Interest coverage ratio-42.3x
CashCN¥925.91m
EquityCN¥2.72b
Total liabilitiesCN¥1.18b
Total assetsCN¥3.89b

Recent financial health updates

No updates

Recent updates

It's A Story Of Risk Vs Reward With Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)

Aug 30
It's A Story Of Risk Vs Reward With Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)

We Ran A Stock Scan For Earnings Growth And Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Passed With Ease

Jul 29
We Ran A Stock Scan For Earnings Growth And Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Passed With Ease

Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181) Held Back By Insufficient Growth Even After Shares Climb 28%

May 13
Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181) Held Back By Insufficient Growth Even After Shares Climb 28%

A Look At The Fair Value Of Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)

May 08
A Look At The Fair Value Of Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)

There's No Escaping Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Muted Earnings

Mar 01
There's No Escaping Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Muted Earnings

Financial Position Analysis

Short Term Liabilities: 300181's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.1B).

Long Term Liabilities: 300181's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥50.7M).


Debt to Equity History and Analysis

Debt Level: 300181 has more cash than its total debt.

Reducing Debt: 300181's debt to equity ratio has reduced from 30% to 8.9% over the past 5 years.

Debt Coverage: 300181's debt is well covered by operating cash flow (158.1%).

Interest Coverage: 300181 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies